Further information regarding event, product, or patient details has been requested.
No additional information is available at this time.
The events is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.
Clarification: the filler was injected into the patient and is not accessible for return.
The syringe was not returned for evaluation.
Clarification: "infection", and "migration" are known potential adverse events addressed in the product labeling.
|
Healthcare professional reports a mid-face lift and moderate postoperative contour deformity.
Patient was treated with injection of an unspecified juvéderm® product in the mid face.
An unspecified amount of time later, unspecified juvéderm® and juvéderm voluma® xc were injected into the midface.
The patient experienced ¿product migration, thinning of the skin, increasing contour deformities at areas adjacent to the injections.
¿ incision and drainage completed at least 7 times as treatment.
The symptoms are ongoing.
Permanent damage probable and noted as ¿skin discoloration, seromas, lack of attachment of skin to soft tissues.
¿ per healthcare professional, "not only was this deforming psychologically devastating, but [patient] still cannot show face in public.
" this is the same event and the same patient reported under mdr id# 3005113652-2020-00464 (allergan complaint #(b)(4)) and mdr id# 3005113652-2020-00466 (allergan complaint #(b)(4)).
This mdr is being submitted for the second injection with an unspecified juvéderm® product.
|